Of 16 antibody‐positive sera, there were 7 (7/46, 15.2%) patients with an ACRBP high expression tumor, and 9 (9/19, 47.3%) patients with an ACRBP low expression tumor. The gene discussed is ACRBP; the disease is neoplasm.